Navigation Links
MIT: Jeremy Nathans to deliver Scolnick Prize lecture

April 23, 2009, Cambridge, MA --- The McGovern Institute for Brain Research at MIT will present the sixth annual Edward M. Scolnick Prize in Neuroscience to Jeremy Nathans, a Howard Hughes Medical Institute Investigator and professor of molecular biology and genetics, neuroscience, and opthalmology at Johns Hopkins University School of Medicine.

Dr. Nathans will deliver the Scolnick Prize lecture entitled "The Evolution of Trichromatic Color Vision" at the McGovern Institute on Monday, April 27, 2009 at 4 pm in the MIT Cognitive Sciences Complex, 43 Vassar Street (building 46, room 3002). The lecture, followed by a reception, is free and open to the public.

The Scolnick Prize is awarded annually by the McGovern Institute to recognize an individual who has made outstanding advances in the field of neuroscience. Nathans will receive the prize for his contributions to the understanding of color vision, brain development, and retinal disease.

"Jeremy Nathans exemplifies the spirit of discovery that we honor through this award," says Robert Desimone, director of the McGovern Institute and chair of the selection committee. "His pioneering work on the mechanism of color vision has led to an extraordinary range of insights into the function and development of the brain, as well as the basis for many forms of human blindness."

In work that he began when he was a graduate student, Nathans solved the mystery of the origin of human color blindness. Using his own DNA, he identified the genes for the three color-sensitive pigment proteins in the human retina. He showed that mutations in these genes cause can lead to different forms of color blindness, and that the red and green pigment genes are on the X-chromosome, which is why red-green color blindness is more common in men than women.

In addition to explaining the molecular basis of color vision, the discovery of these pigment proteins and the related protein rhodopsin was important because they are prototypes of a large family of proteins known as G-protein-coupled receptors. These proteins are key signaling molecules in all known organisms, and they represent the targets for about 1/3 of all FDA-approved drugs.

In more recent studies, Nathans and his colleagues discovered how genes control the normal development of the retina, and how defects in these genes disrupt the function and survival of retinal cells. These studies have revealed several defects that lead to human retinal diseases including Stargardt disease, the most common type of macular degeneration in children and young adults.

Nathans and colleagues also determined that the vitelliform type of macular dystrophy is caused by abnormalities in a member of a previously unknown family of ion channels proteins that allow ions to enter and exit cells.


Contact: Julie Pryor
McGovern Institute for Brain Research

Related biology news :

1. Jeremy Jackson honored by Harvard Museum of Natural History
2. New type of vaccines deliver stronger and faster immune response
3. Depression during pregnancy can double risk of preterm delivery
4. Self-assembling nano-fiber gel delivers high concentrations of clinically approved drugs
5. RNA molecules, delivery system improve vaccine responses, effectiveness
6. Sig-Tec(R) and BIO-key(R) Deliver Advanced Biometric Security Solution to Ohio County Law Enforcement Agency
7. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
8. ID Solutions Achieves Full-Production Delivery and Payment for Fingerprint Processing Software for TWIC
9. Promptu and OAG Team to Deliver Flight Schedule and Status Information on Mobile Devices
10. Energy secretary, IEEE-member industry leader to deliver keynote addresses during GridWeek 2008
11. Slipping through cell walls, nanotubes deliver high-potency punch to cancer tumors in mice
Post Your Comments:
Related Image:
MIT: Jeremy Nathans to deliver Scolnick Prize lecture
(Date:11/12/2015)... golden retriever that stayed healthy despite having the gene ... new lead for treating this muscle-wasting disorder, report scientists ... and Harvard and the University of São Paolo in ... pinpoints a protective gene that boosts muscle regeneration, ... Children,s lab of Lou Kunkel , PhD, is ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:10/29/2015)... Oct. 29, 2015   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... Association (MHTA) as one of only three finalists for ... – Small and Growing" category. The Tekne Awards honor ... shown superior technology innovation and leadership. ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... LUMPUR, Malaysia , Nov. 24, 2015 /PRNewswire/ ... global contract research organisation (CRO) market. The trend ... result in lower margins but higher volume share ... increased capacity and scale, however, margins in the ... Research Organisation (CRO) Market ( ), ...
(Date:11/24/2015)... 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will ... New York on Wednesday, December 2 at 9:30 a.m. ... and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola ... a corporate overview. --> th Annual Oppenheimer Healthcare ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... the year and one of the premier annual events for pharmaceutical manufacturing: 2015 ... 8–11 November 2015, where ISPE hosted the largest number of attendees in more ...
(Date:11/24/2015)... 2015 --> ... "Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, ... DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) ... market is expected to reach USD 1,918.6 Million by ... CAGR of 10.1% during the forecast period. ...
Breaking Biology Technology: